Oncolys BioPharma Inc. (TYO:4588)
2,724.00
+111.00 (4.25%)
Jun 24, 2026, 12:45 PM JST
Oncolys BioPharma Employees
Oncolys BioPharma had 44 employees as of March 31, 2026. The number of employees increased by 3 or 7.32% compared to the same quarter last year.
Employees
44
Change
3
Growth
7.32%
Revenue / Employee
679.67K JPY
Profits / Employee
-48.93M JPY
Market Cap
76.54B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 44 | 3 | 7.32% |
| Sep 30, 2025 | 42 | 4 | 10.53% |
| Jun 30, 2025 | 41 | 3 | 7.89% |
| Mar 31, 2025 | 41 | 3 | 7.89% |
| Dec 31, 2024 | 40 | 0 | - |
| Sep 30, 2024 | 38 | 0 | - |
| Jun 30, 2024 | 38 | -2 | -5.00% |
| Mar 31, 2024 | 38 | 1 | 2.70% |
| Dec 31, 2023 | 40 | 2 | 5.26% |
| Sep 30, 2023 | 38 | 2 | 5.56% |
| Jun 30, 2023 | 40 | 2 | 5.26% |
| Mar 31, 2023 | 37 | 1 | 2.78% |
| Dec 31, 2022 | 38 | 2 | 5.56% |
| Sep 30, 2022 | 36 | 1 | 2.86% |
| Jun 30, 2022 | 38 | 2 | 5.56% |
| Mar 31, 2022 | 36 | -1 | -2.70% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| GNI Group | 990 |
| PeptiDream | 645 |
| Nxera Pharma | 354 |
| Japan Tissue Engineering | 204 |
| RaQualia Pharma | 85 |
| Healios K.K. | 75 |
| Cuorips | 56 |
| AnGes | 56 |